
-
BioSig Technologies NasdaqCM:BSGM BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of signal processing, physiologic recording, electrophysiology recording, electrophysiology software, and autonomics to develop, make, and offer for sale. The company also designs and develops an online platform for real-world asset (RWA) tokenization. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Los Angeles, California.
Location: 12424 Wilshire Blvd, Los Angeles, CA, 90025, United States | Website: https://www.biosig.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
149.3M
Cash
3.727M
Avg Qtr Burn
-1.14M
Short % of Float
5.51%
Insider Ownership
17.56%
Institutional Own.
44.16%
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PURE EP™ (device) Details Heart disease, Medical device | Approved Quarterly sales | |
Merimepodib (MMPD) Details COVID-19 | Failed Discontinued |